Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial.
Extra Virgin Olive Oil and the Gut-Brain Axis: A New Frontier in Cognitive Preservation and Metabolic Health
The traditional Mediterranean diet has long been heralded as the gold standard for cardiovascular longevity, but a groundbreaking prospective study…
Read More
Breakthrough in MXene Synthesis Achieves Unprecedented Electrical Conductivity and Surface Precision Through Novel Molten Salt Technique
A collaborative research effort led by the Institute of Ion Beam Physics and Materials Research at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR)…
Read More
Unraveling the Evolutionary Enigma of Yeast Centromeres: Researchers Discover "Proto-Point" Ancestor, Revealing Repurposed Parasitic DNA
Centromeres, the vital chromosomal regions responsible for ensuring accurate cell division, exhibit a profound paradox: while their fundamental function is…
Read More
Unprecedented Growth Rates and Early Genetic Origins of Chronic Myeloid Leukemia Revealed in Landmark Genomic Study
A comprehensive genomic study published in the journal Nature has fundamentally altered the scientific understanding of chronic myeloid leukemia (CML),…
Read More
Lilly Ascends to Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s Explosive Growth
Eli Lilly and Company has officially claimed the top position in the global pharmaceutical industry by revenue for fiscal year…
Read More
Plasma Rotation Solves Decades-Old Mystery of Particle Imbalance in Fusion Tokamaks
For decades, the global scientific community has pursued the "holy grail" of energy: nuclear fusion. By replicating the processes that…
Read More
Unveiling the Molecular Choreography of Bacterial Cell Division: UAB Scientists Decode MraZ Protein’s Crucial Role
A groundbreaking discovery by a research team spearheaded by David Reverter, a scientist at the Universitat Autònoma de Barcelona (UAB),…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment Through Epigenetic Reprogramming
Acute Myelogenous Leukemia (AML) has long remained one of the most formidable challenges in oncology, characterized by its rapid progression…
Read More
MEDVi: The AI-Powered Telehealth Startup Under Fire Amidst FDA Warnings, Deception Allegations, and Mounting Lawsuits
In an era increasingly shaped by artificial intelligence, the promise of rapidly scalable, AI-driven enterprises has captivated the global imagination.…
Read More